Haplotype construction of DNA markers in five consanguineous linked families showed that a segment of homozygosity has been conserved for D16S3070 and D16S2617. No other DNA markers showed any such conservation. Therefore, we suggested that these two markers reside in close proximity to the FMF locus. Furthermore, we observed 80% allelic association with D16S2617 but no association with D16S3070 or any other DNA markers from the FMF critical region. In summary, we conclude that our Turkish families are also linked to the reported FMF locus at 16p13.3, there is a genetic heterogeneity for this condition at least in our group of Turkish families, and D16S2617 is in linkage disequilibrium in the Turkish FMF families. Combination of this study with previously published observations suggests that the FMF locus resides between D16S246 and D16S3070/D16S2617 and within a region of about 250-300 kb.
Turks. Genetic linkage study of a large group of non-Turkish families has previously mapped the FMF locus to the 16pl3.3 region and shown that this locus resides 0.305 cM distal to D16S246. Furthermore, allelic association has also been shown with D16S3070 (75%) and D16S3275 (66%). However, no genetic heterogeneity has been described for any of the three major reported groups of FMF families. Here, we describe the genetic linkage relationship of the fourth major group of Turkish families and report the first evidence for genetic heterogeneity of this condition. Two point linkage analysis and haplotype inspection of 15 DNA markers from the reported region ofthe FMF locus identified tight linkage in a group of six Turkish FMF families. A maximum lod score of 9.115 at 0=0.00 was observed for D16S3024. Nine other DNA markers provided similar evidence of linkage with lod score values of above 5.21. However, two other FMF families were completely unlinked to this region of chromosome 16. Haplotype construction of DNA markers in five consanguineous linked families showed that a segment of homozygosity has been conserved for D16S3070 and D16S2617. No other DNA markers showed any such conservation. Therefore, we suggested that these two markers reside in close proximity to the FMF locus. Furthermore, we observed 80% allelic association with D16S2617 but no association with D16S3070 or any other DNA markers from the FMF critical region. In summary, we conclude that our Turkish families are also linked to the reported FMF locus at 16p13.3, there is a genetic heterogeneity for this condition at least in our group of Turkish families, and D16S2617 is in linkage disequilibrium in the Turkish FMF families. Combination of this study with previously published observations suggests that the FMF locus resides between D16S246 and D16S3070/D16S2617 and within a region of about 250-300 kb.
(JMed Genet 1997;34:573-578) Keywords: familial Mediterranean fever; genetic linkage; 16p 1 3.3 ; Turkish population Familial Mediterranean fever (FMF), also known as recurrent polyserositis is an autosomal recessive disorder characterised by recurrent, self limiting attacks of fever accompanied by peritonitis, arthritis, or pleurisy. 1 The disease is almost completely restricted to nonAskhenazi Jews, Arabs, Armenians, and Turks.2 3 Other subjects affected with this condition have also been reported from different populations, but for most of these patients the exact ancestry cannot be determined. 4 The fetal complication of FMF is the development of secondary amyloidosis. There is a striking difference in the frequency of amyloid nephropathy in different ethnic groups. It is known to be more frequent in Turks and nonAskhenazi Jews with a frequency of 60% and 12-30%, respectively.57 However, the phenotypic expression of the disease is less severe, with a low incidence of amyloidosis in Iraqi Jews, Arabs, and Armenians.8 Recurrent attacks and the development of amyloidosis can be prevented by colchicine treatment.9 10 Despite numerous efforts to understand the basic mechanism underlying the FMF phenotype, the exact molecular mechanism of this condition is still unknown.
The FMF locus has been mapped to chromosome 16pl 3.3 within an interval that is flanked by D1 6S246 telomerically and D16S523/D16S423 centromerically." 12 Linkage disequilibrium between the FMF locus and a 2.5 kb fragment of D16S246 has been reported in Moroccan and non-Moroccan Jews, but not among Armenian or Arab families.'3 These linkage disequilibrium data have placed the FMF gene approximately 0.305 cM distal to D16S246. 13 In a more recent report, the FMF locus was shown to be tightly linked to two markers, D16S3070 and D16S3275, in non-Askhenazi Jews. 14 These two DNA markers are both reported to be localised to a 250 kb fragment.'4 To date, three out of the four major FMF groups, namely, Jewish, Armenian, and Arabs, have been extensively studied for both linkage and haplotype transmission analysis, but so far no locus heterogeneity has been reported for any of these populations. In this study, we aimed to evaluate the last major group, the Turks, by testing for linkage and genetic heterogeneity of Akarsu, Saatci, Ozeni, Bakkaloglu, Besbas, Sarfarazi Five of the linked families used in this study were the result of consanguineous marriages which allowed us to construct the common inherited haplotypes. As shown in table 4, the smallest segment of homozygosity was observed in families 4 and 8, suggesting that D16S3070 and D16S2617 are the two minimum segments of DNA that have been conserved in these families. None of the markers above or below these two markers showed the same homozygosity in these consanguineous families. Therefore, we were able to position D1 6S2617 in very close proximity to D16S3070. This homozygosity in the affected subjects also suggests that FMF may reside very close to these two markers.
Discussion
In this report, we present evidence that in a group of Turkish FMF families the FMF gene is also linked to the same reported region of 16p 13.3. Thus, we confirmed that this location is a major locus responsible for the FMF phenotype that occurs in different populations with various ethnic backgrounds. Six out of eight families studied here provided positive lod scores for all the STRP markers from this region of chromosome 16. A group of tightly linked markers did not show any recombination with the FMF locus. A maximum lod score of 9.115 at 0=0.00 was obtained for DNA marker D 16S3024. Other DNA markers from this region of chromosome 16 also showed strong linkage with all the six linked families. We have also observed 80% allelic association with marker D 16S2617 in our group of linked families. Furthermore, all of our consanguineous family members showed homozygosity for this marker. Previously, another allelic association (76%) was also reported with closely linked marker D16S246 in the Moroccan Jewish population, and in a recent report, 75% and 66% allelic association has been described for D16S3070 3. Surprisingly, two Turkish families showed no linkage to this region of chromosome 16 , thus providing the first evidence of genetic heterogeneity in this disorder (fig 2) . The affected members of these two families were revisited and their members were resampled and subsequently regenotyped for all the DNA markers studied. The diagnosis in the two unlinked families was confirmed and was based on their recurrent, self-limiting attacks of fever and synovitis. These attacks have responded well to colchicine with resolution of these attacks in all the affected members. One distinctive phenotypic feature in these two families is that they have had pronounced attacks of arthritis. Rheumatoid arthritis was excluded by the lack of joint deformity, the short duration of the arthritis, and spontaneous resolution of the joint findings. Behcet's disease was also excluded as the result of lack of clinical criteria. 28 The IgD levels of the affected subjects from these two unlinked families were found to be normal based on the differential diagnosis of periodic fever with hyperimmunoglobulinaemia D syndrome.29 Therefore, the clinical diagnosis and genotypic data were confirmed in these two families. In addition, no indication for linkage was obtained with markers from other candidate regions on chromosome 1 7q.
Phenotypic variation between people of different ethnic origin is well known in this condition. For example, in the Arab population, FMF is less severe with low incidences of arthritis, amyloidosis, and erysipeloid erythema.4 Similarly, while amyloidosis and arthritis are less common in Armenians, pleuritis seems more frequent in this population. 30 In Turks, amyloidosis is relatively more common. However, erysipelis-like lesions are very rare in the Turkish population (unpublished observations). In this study, two families (families 3 and 12) showed complications of amyloidosis (table 1) . However, one of them (family 3) showed no linkage to chromosome 16 , while the other one showed tight linkage to all the DNA markers studied from this region. Therefore, this locus heterogeneity cannot be attributed to the phenotypic variation. A study is currently under way to screen other kindreds, aiming to identify more families unlinked to this region of chromosome 16. We are indebted to the FMF families who participated in this study. We would like to thank Dr M Ozguc, director of the DNA/Cell Bank and Gene Research Laboratory of the Scientific and Technical Council of Turkey (TUBITAK) for extraction and banking of the FMF DNA samples. This work is partially supported by "The State Planning Organization of the Turkish Republic".
